Xingchen Peng

57PUBLICATIONS
55CO-AUTHORS
Radiation therapyMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Oct 30, 2026
Limosilactobacillus reuteri for oral mucositis in patients undergoing radiotherapy for malignant head and neck tumors: a randomized controlled trial.

|Oct 23, 2026
Biomimetic Nanoplatform for Fibrosis Remodeling and Anti-PD-1 Potentiation via Cu+/Ca2+ Ion Dysregulation and TGF-β Inhibition in PDAC.

|Oct 23, 2026
Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation.

|Oct 12, 2026
Trajectories of Plasma Epstein-Barr Virus DNA and Clinical Outcomes in Recurrent or Metastatic Nasopharyngeal Carcinoma Treated With PD-L1 Inhibitors: A Post-Hoc Analysis of a Multicenter, Phase II Study.

|Oct 05, 2026
Hypoxia-Regulating Nanozymes for Biomedicine.

|Sep 12, 2026
Neoadjuvant chemoimmunotherapy with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-2): an open-label, single-arm, phase 2 study.

Pageof 10

Frequent Collaborators

8 joint publications

Zheran Liu

6 joint publications

Jingjing Wang

5 joint publications

Hui Guan

3 joint publications

Yiyan Pei